Inter-fractional monitoring of [Formula: see text]C ions treatments: results from a clinical trial at the CNAO facility.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 11 2020
26 11 2020
Historique:
received:
14
04
2020
accepted:
13
11
2020
entrez:
27
11
2020
pubmed:
28
11
2020
medline:
16
3
2021
Statut:
epublish
Résumé
The high dose conformity and healthy tissue sparing achievable in Particle Therapy when using C ions calls for safety factors in treatment planning, to prevent the tumor under-dosage related to the possible occurrence of inter-fractional morphological changes during a treatment. This limitation could be overcome by a range monitor, still missing in clinical routine, capable of providing on-line feedback. The Dose Profiler (DP) is a detector developed within the INnovative Solution for In-beam Dosimetry in hadronthErapy (INSIDE) collaboration for the monitoring of carbon ion treatments at the CNAO facility (Centro Nazionale di Adroterapia Oncologica) exploiting the detection of charged secondary fragments that escape from the patient. The DP capability to detect inter-fractional changes is demonstrated by comparing the obtained fragment emission maps in different fractions of the treatments enrolled in the first ever clinical trial of such a monitoring system, performed at CNAO. The case of a CNAO patient that underwent a significant morphological change is presented in detail, focusing on the implications that can be drawn for the achievable inter-fractional monitoring DP sensitivity in real clinical conditions. The results have been cross-checked against a simulation study.
Identifiants
pubmed: 33244102
doi: 10.1038/s41598-020-77843-z
pii: 10.1038/s41598-020-77843-z
pmc: PMC7693236
doi:
Substances chimiques
Ions
0
Carbon
7440-44-0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20735Références
Rep Prog Phys. 2016 Sep;79(9):096702
pubmed: 27540827
Phys Med Biol. 2014 Apr 7;59(7):1857-72
pubmed: 24625560
Phys Med Biol. 2013 Dec 7;58(23):8265-79
pubmed: 24216465
Phys Med Biol. 2018 Sep 17;63(18):185019
pubmed: 30033938
Front Oncol. 2016 Aug 03;6:177
pubmed: 27536555
Phys Med. 2017 Feb;34:18-27
pubmed: 28111101
Med Phys. 2016 Apr;43(4):1995
pubmed: 27036594
Phys Med Biol. 2018 Jul 17;63(14):145018
pubmed: 29873299
Sci Rep. 2018 Mar 6;8(1):4100
pubmed: 29511282
Int J Part Ther. 2016 Winter;2(3):428-438
pubmed: 31772953
Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):210-218
pubmed: 28816148
Radiat Oncol. 2017 Jun 8;12(1):94
pubmed: 28595643
Phys Med Biol. 2012 Aug 7;57(15):5017-34
pubmed: 22805295
Phys Med. 2019 Sep;65:84-93
pubmed: 31437603
Phys Med Biol. 2018 Mar 07;63(5):055018
pubmed: 29265011
Phys Med. 2018 Jul;51:71-80
pubmed: 29747928
Phys Med Biol. 2014 Nov 21;59(22):R419-72
pubmed: 25361443
Nat Rev Clin Oncol. 2017 Aug;14(8):483-495
pubmed: 28290489
Radiother Oncol. 2014 Oct;113(1):66-71
pubmed: 25156944
J Med Imaging (Bellingham). 2017 Jan;4(1):011005
pubmed: 27981069
Phys Med Biol. 2013 Aug 7;58(15):R131-60
pubmed: 23863203
Front Oncol. 2016 May 11;6:116
pubmed: 27242956